News Briefs Cancer drug developer Erasca picks up $42 mln Series A Iris Dorbian - 18 December 2018 Share A- A+ 100% Create an account to continue reading Gain instant access to our expert editorial analysis and in-depth insight. Register for free Already have an account? Sign in
